Search Results

240 results for bmti

Catch Bristol-Myers Squibb Co (BMY) Stock With Confidence

By Nicolas Chahine, InvestorPlace Contributor

Catching a pharma falling knife is dangerous work, but if you’re careful in Bristol-Myers Squibb, you can make money with BMY stock.

Bristol-Myers Squibb Earnings: BMY Stock Bounces on Strong Q2, Guidance

By William White, InvestorPlace Writer

Bristol-Myers Squibb earnings for the second quarter of the year have BMY stock on the move Thursday after it beat estimates.

Why Bristol-Myers Squibb (BMY), Immunogen (IMGN) and LinkedIn (LNKD) are 3 of Today’s Best Stocks

By Ethan Roberts, InvestorPlace Contributor

Modest economic improvements and a major medical conference lifted the markets, especially Bristol-Myers, Immunogen and LinkedIn.

3 Medical Devices Stocks to Sell Now

By Portfolio Grader

This week, the overall grades of three Medical Devices stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”)…

Tuesday’s Biggest Stock Losers: TRGT, JCP, and More

By Karl Utermohlen, InvestorPlace Writer

TRGT tops the list of Tuesday morning’s biggest stock losers. JCP, RMTI, CBMX, OPK and a couple others round up the list.

8 Medical Devices Stocks to Buy Now

By Portfolio Grader

The grades of eight medical devices stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong…

3 Dividend Stocks to Buy at a 52-Week Low in April

By Nikolaos Sismanis, InvestorPlace Contributor

Explore these three dividend stocks trading near their 52-week lows, presenting compelling opportunities for income-oriented investors.

Undervalued Bristol-Myers Squibb Stock Is Worth 50% More

By Mark R. Hake, CFA

BMY stock looks cheap here. Bristol-Myers is a defensive value with an attractive yield, cheap valuation, and plenty of potential upside.

3 Stocks Facing Tax-Loss Selling That Will See a 2024 Rebound

By Ian Bezek, InvestorPlace Contributor

Tax-loss selling takes on a life of its own at the end of the year. Buy these three tax-loss stocks now to cash in on…

Carl Icahn’s Stake in Bristol-Myers Squibb Co (BMY) Fuels Takeover Talk

By William White, InvestorPlace Writer

Bristol-Myers Squibb Co (BMY) may be the next target for a takeover by Carl Icahn now that he’s taken a large stake in the company.

3 Potential Turnaround Stocks to Buy for Big Rewards in 2024

By Ian Cooper, InvestorPlace Contributor

There was plenty to get excited about in 2023 and even more to get excited about with turnaround stocks in the new year.

Why Allergan plc Ordinary Shares (AGN), AMN Healthcare Services, Inc. (AHS) and Bristol-Myers Squibb Co (BMY) Are 3 of Today’s Worst Stocks

By James Brumley, InvestorPlace Feature Writer

Owners of Bristol-Myers Squibb (BMY), Allergan (AGN) and AMN Healthcare Services (AHS) are wishing the weekend lasted one more day today.

4 Biotech Stocks to Buy That Are on the Move

By William Roth, InvestorPlace Market Strategist

Biotech stocks overall are holding up fairly well amid recent market volatility. Look at which four biotech stocks to buy have staying power.

Best Stocks for 2022: Bristol-Myers Squibb Is Having a Great Year

By Sure Dividend

BMY stock is up 21% this year. That’s impressive compared to the market as a whole, which has entered bear territory, and it has room…

5 Health Care Equipment & Supplies Stocks to Sell Now

By Portfolio Grader

The overall ratings of 5 Health Care Equipment & Supplies stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”)…

Patient Investors Will Stick With Very Cheap Bristol-Myers Squibb Stock

By Mark R. Hake, CFA

Stick with Bristol-Myers Squibb stock which is incredibly cheap. BMY stock is worth at least 46% more than today, based on its historical yield, P/E…

Why These 3 Top Stocks Are Better Buys Than Dogecoin

By David Cohne, StockNews.com

After experiencing a massive rally last week, Dogecoin has plummeted over 30% in the past few days. Many believe the cryptocurrency is headed even lower.…

If You Can Only Buy One Long-Term Stock in December, It Better Be One of These 3 Names

By Marie Brodbeck, InvestorPlace Contributor

These three long-term stocks are poised for impressive growth not matter the economic weather in the years ahead.

Flextronics, Bristol-Myers Top Midday Options

By Andrew Wilkinson, Interactive Brokers

Options midday see volume in a huge straddle in Flextronics (NASDAQ: FLEX), and Bristol-Myers (NYSE: BMY) action after Goldman recommendation.

Bristol-Meyers Squibb News: Why BMY Stock Is Falling Today

By William White, InvestorPlace Writer

Bristol-Meyers Squibb news for Monday has BMY stock taking a beating after announcing a delay to its merger deal with Celgene.

5 Smoking Hot Tobacco Stocks to Buy Now

By Louis Navellier, Editor, Growth Investor

Tobacco stocks are not all just about cigarettes and smoking, as these companies provide steady earnings and dividends that can boost your portfolio yields.

4 Commercial Banking Stocks to Buy Now

By Portfolio Grader

This week, four Commercial Banking stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall…

3 Investments to Make to Protect Your Wealth in a Downturn

By Marie Brodbeck, InvestorPlace Contributor

These three stocks are well placed to weather a recession, making them good investments to protect your wealth.

Bristol-Myers Squibb Co (BMY) Stock Falls on Earnings Miss

By William White, InvestorPlace Writer

Bristol-Myers Squibb (BMY) stock was down today following the release of its earnings report for the third quarter of 2017.

7 – 10 of 240 results